Your browser does not support JavaScript or it may be disabled!
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
Get Realtime News
on your webpage

About 800 results for "sandoz inc"

The Medicines Company Reports Third-Quarter 2016 Financial Results

global Biosimilars Market Report 2016-2025: Key Companies are ...

Dublin, Oct. 28, 2016 (GLOBE NEWSWIRE) -- Research and Markets has announced the addition of the report to their offering. The market for biosimilars offers tremendous growth opportunities for the operating companies to record high revenue growth. Yahoo! Finance, 9 hours ago
American Banking News

Innoviva's (INVA) CEO Michael Aguiar on Q3 2016 Results - Earnings Call Transcript

Innoviva, Inc. (NASDAQ: INVA ) Q3 2016 Earnings Conference Call October 27, 2016 5:00 PM ET Executives Eric dEsparbes - Senior Vice President and Chief Financial Officer Michael Aguiar - President and Chief Executive Officer ...
 Seeking Alpha19 hours ago Edited Transcript of PTX earnings conference call or presentation 11-Aug-16 8:30pm GMT  Yahoo! Finance4 days ago FY2016 EPS Estimates for Novartis AG (NVS) Decreased by Analyst  American Banking News1 day ago Novartis AG (NVS) Q3 2016 Results - Earnings Call Transcript  Seeking Alpha2 days ago

Upsher-Smith Acquires 20 Generic Drug Products

MAPLE GROVE, Minn., Oct. 18, 2016 /PRNewswire/ -- Upsher-Smith Laboratories, Inc. (Upsher-Smith) today announced that it has acquired more than 20 US generic products from Sandoz, Inc. for an upfront payment in cash and additional payments ...
 Yahoo! Finance1 week ago Upsher-Smith Laboratories Acquires 20 Generic Drug Products  BioSpace1 week ago

A Compelling Risk/Reward Seen In Momenta Pharmaceuticals

Barclays sees a compelling risk/reward in Momenta Pharmaceuticals, Inc. (NASDAQ: MNTA ) citing the Copaxone 40mg trial. The firm sees little risk in owning the stock pointing out successful IPR decisions, although no one could guarantee whether the ...
 Benzinga.com2 weeks ago

FDA Accepts Coherus's aBLA for Neulasta® Biosimilar

In August, we reported that Coherus Biosciences, Inc. submitted an aBLA for CHS-1701, a pegfilgrastim (Neulasta®) biosimilar candidate. Last week, Coherus announced that FDA has accepted its aBLA. Under the BPCIA, Coherus has 20 days from FDA ...
 JD Supra2 weeks ago Coherus' Neulasta Biosimilar At FDA Altar, CytoDyn On Fast Track, VIVE Abuzz  RTTNews.com3 weeks ago

Coherus Biosciences Could Be First-To-Market With A Neulasta Biosimilar

Barclays maintained its Overweight rating on Coherus Biosciences Inc (NASDAQ: CHRS ) saying there is an increased likelihood of CHRS being first-to-market with a Neulasta biosimilar (CHS-1701) after Sandoz's complete response letter. Neulasta is ...
 Benzinga.com3 weeks ago

TWi Confirms Patent Challenge Relating to Its Paragraph IV ANDA Filing for a Generic Equivalent to Androgel 1.62%

Monday, September 19, 2016 TWi Pharmaceuticals, Inc. confirmed today that it has filed an Abbreviated New Drug Application (ANDA) containing a Paragraph IV certification with US FDA seeking approval to market a generic version of Androgel 1.62%, ...
 Pharma Focus Asia1 month ago

Amgen (AMGN) Q3 Earnings & Sales Top; Enbrel Hurts Stock

Biotech major, Amgen Inc. AMGN reported third-quarter 2016 earnings of $3.02 per share, beating the Zacks Consensus Estimate of $2.79 by 8.24% and increasing 11% from the year-ago period. Total revenues increased 2% to $5.81 billion in the third ...
 Yahoo! Canada6 hours ago

7 Drug Stocks to Consider as Biosimilars Pick Up Pace

Interest in biosimilars has picked up considerably with Pfizer, Inc.'s ( PFE - Analyst Report ) announcement this week regarding its plans to launch a biosimilar version of Johnson & Johnson's blockbuster drug, Remicade, in late November. What ...
 Zacks.com1 week ago

Pink Sheet - How Risky Is Pfizer's Launch Of Its Remicade Biosimilar?

Executive Summary Following Sandoz's Zarxio playbook, Pfizer plans to market Inflectra while patent litigation continues; February 2017 trial on cell culture media patent could answer question of potential damages. Celltrion Inc. and partner ...
 Friends of Cancer Research1 week ago Pfizer to Launch Remicade Biosimilar in U.S. in November  Yahoo! Singapore1 week ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts


Realtime News

on your Webpage

Add Widget >Get your members hooked!
Get updated on latest news & your favorite topics right in your inbox!
More     Less